Hana Golan
- Spécialisation: Hematologist
- 24 années d'expérience
- Parle:English, Hebrew
- Espace de travail: Israël, Ramat Gan, Centre médical Sheba
- Serves as Director of Pediatric Hemato-Oncology & BMT and Principal Investigator of the High-Risk Neuroblastoma ESIOP protocol.
Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.
- National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
- Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
- Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
- Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.
Explorez les forfaits avec le Dr Hana Golan
Greffe de moelle osseuse pour ostéosarcome pédiatrique à l'hôpital Sheba - Accrédité JCI et classé parmi les 10 meilleurs hôpitaux 2025 par Newsweek
Greffe de moelle osseuse pour le médulloblastome pédiatrique
Greffe de moelle osseuse pour le sarcome d'Ewing pédiatrique
Greffe de cellules souches autologues (greffe de moelle osseuse autologue) pour la tumeur de Wilms pédiatrique
Services du médecin
- Chimiothérapie
- Chimiothérapie du lymphome
- Thérapie biologique
- Plasmaphérèse
- Transplantation allogénique de moelle osseuse provenant d'un donneur non apparenté
- Échange de plasma
- Аphérèse thérapeutique
- Une greffe de moelle osseuse
- Thérapie CAR T
- Chimiothérapie contre la leucémie
- Transplantation de cellules souches haploidentiques
- Transplantation allogénique de moelle osseuse d'un donneur apparenté
- Plasmaphérèse DFPP
- Аphérèse sélective
- Immunothérapie
- Immunothérapie avec Keytruda (Pembolizumab)
- Dissection des ganglions lymphatiques
- Lymphadénectomie
- Traitement conservateur
- Traitement symptomatique
- Traitement hospitalier par jour
- Traitement médical
- Cours de traitement avec ses propres cellules souches
- Thérapie par cellules souches mésenchymateuses
- Traitement du sang de cordon ombilical
- Conseils individuels
- Cours de traitement avec des cellules souches de donneurs
- Thérapie à base de cellules souches embryonnaires
- Ultrason
- CT (tomodensitométrie)
- Biopsie
- Test sanguin avec marqueur tumoral
- Immunohistochimie
- IRM d’une zone
- TEP/TDM
- Mammographie
- IRM corps entier
- Coloscopie
- Typage HLA
- Biopsie de moelle osseuse
- Consultation en ligne avec un oncologue
- IRM cérébrale
Où en sommes-nous ?
Qualifications
Dr. Hana Golan is the Director of the Pediatric Hemato-Oncology and BMT Division at Sheba Medical Center. She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. Dr. Golan treats complex childhood cancers at a facility ranked among the top 10 hospitals worldwide. She also leads one of the most advanced pediatric oncology programs in the region.
Specialization and Clinical Focus
Dr. Golan treats high-risk pediatric cases using oncology and stem cell transplantation protocols. Her work involves childhood hematologic malignancies and aggressive solid tumors. This clinical focus includes treats several conditions, including:
- Neuroblastoma and high-risk solid tumors
- Leukemia, including acute lymphoblastic leukemia
- Lymphomas, such as Hodgkin's and Non-Hodgkin's types
- Aplastic anemia and other bone marrow failure syndromes
- Sickle cell anemia and inherited blood disorders
- Immune deficiencies and metabolic disorders
The doctor performs procedures such as CAR T-cell therapy and allogenic bone marrow transplants. She uses haploidentical stem cell transplantation and personalized chemotherapy to improve outcomes. Dr. Golan also implements computerized safety protocols for chemotherapy administration. Additionally, she developed systems to improve clinical workflow and patient safety.
Research and Clinical Trials
Dr. Golan coordinates international multicenter oncology protocols to advance pediatric care. She serves as an investigator in international Phase I and II clinical trials. Her research investigates cancer stem cells and novel targeted therapies. The specialist also explores emerging therapeutic strategies involving cannabinoid-related oncology for treatment-resistant malignancies.
Academic and Professional Roles
- Director, Pediatric Hemato-Oncology and BMT Division, Sheba Medical Center
- Senior Lecturer, Sackler Faculty of Medicine, Tel Aviv University
- National Coordinator of multicenter oncology protocols
- Coordinator of hematology training programs for medical students
- Lecturer in pediatric hematology-oncology for physicians and nurses
Education and Training
- Medical Degree (MD), Rappaport Faculty of Medicine, Technion – Israel Institute of Technology
- Residency in Pediatrics, Sheba Medical Center
- Residency in Pediatric Hematology-Oncology, Sheba Medical Center
- Research Training in Transplantation Immunology, Weizmann Institute of Science
- Advanced training in clinical research, biomedical informatics, and healthcare management
- Board Certification in Pediatrics
- Board Certification in Pediatric Hematology-Oncology
Professional Publications
Dr. Golan contributes to peer-reviewed literature regarding pediatric cancer treatments. Notable works include:
- "Primary immunodeficiency syndromes in Israel"
- "Integration of palliative care in pediatric oncology"
Vous pourriez aussi être intéressé
Paiement et récompenses
Vous ne payez pas pour nos services
Vous effectuez votre paiement directement à la clinique ou sur leur compte bancaire officiel.
Certaines cliniques peuvent exiger un acompte dans le cadre de leur politique.
Étalez vos paiements avec des options de versements.
Gagnez des récompenses en parrainant vos amis sur Bookimed.